Mårten Wigstøl
Chairman at Cimon Medical AS
Profile
Mårten Wigstøl is the founder of GenoVision AS.
He currently holds positions as Chairman at Cimon Medical AS, Director at Magnetic Biosolutions AB, Director at Barracuda Invest AS, and Director at Defibrio AS.
He formerly held the position of Chief Executive Officer & Head-Investor Relations at NORDA ASA. He holds an MBA from Henley Business School Ltd.
and an undergraduate degree from the University of Laurentian.
Mårten Wigstøl active positions
| Companies | Position | Start |
|---|---|---|
Magnetic Biosolutions AB
 Magnetic Biosolutions AB Medical SpecialtiesHealth Technology Magnetic Biosolutions AB develops medical instruments and software. The company specializes in the development of instruments, software, and protocols for sample preparation using magnetic bead technology. It was founded in 2000 and is headuqartered in Stockholm, Sweden. | Director/Board Member | - |
| Barracuda Invest AS | Director/Board Member | - |
Cimon Medical AS
 Cimon Medical AS Electronic Equipment/InstrumentsElectronic Technology Cimon Medical AS develops and manufactures applications for continuous monitoring blood flow. The company is based in Trondheim, Norway. The Norwegian company was founded in 2019 by Tormod Thomsen, Siri Ann Nyrnes. Tormod Thomsen has been the CEO since 2019. | Chairman | - |
Defibrio AS
 Defibrio AS Medical SpecialtiesHealth Technology Defibrio AS is a Norwegian company that focuses on saving lives by providing immediate access to automatic external defibrillators (AEDs). The company is based in Fana, Norway and was founded in 2020. The company's mission is to increase the survival rate of sudden cardiac arrest (SCA), which currently has a low survival rate of 10%%. SCA kills millions of people worldwide every year, with 70%% of deaths occurring in the home. Defibrio aims to reduce the chance of death by providing quick access to AEDs. The CEO is Arne Gjerde Bergby. | Director/Board Member | - |
Former positions of Mårten Wigstøl
| Companies | Position | End |
|---|---|---|
| NORDA ASA | President | - |
GenoVision AS
 GenoVision AS Medical SpecialtiesHealth Technology GenoVision AS develops reagents and solutions for certain nucleic acid diagnostic markets. It has developed products and protocols for the direct isolation of DNA and RNA from a variety of sample sources such as dried blood, leucocytes, serum, buccal cells, cultured cells, biopsy samples, paraffin embedded tissue sections, animal tissue and yeast cells. GenoVision was formed in 1998 and is headquartered in Oslo, Norway | Founder | - |
Training of Mårten Wigstøl
| Henley Business School Ltd. | Masters Business Admin |
| University of Laurentian | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| NORDA ASA | Commercial Services |
| Private companies | 5 |
|---|---|
GenoVision AS
GenoVision AS Medical SpecialtiesHealth Technology GenoVision AS develops reagents and solutions for certain nucleic acid diagnostic markets. It has developed products and protocols for the direct isolation of DNA and RNA from a variety of sample sources such as dried blood, leucocytes, serum, buccal cells, cultured cells, biopsy samples, paraffin embedded tissue sections, animal tissue and yeast cells. GenoVision was formed in 1998 and is headquartered in Oslo, Norway | Health Technology |
Magnetic Biosolutions AB
Magnetic Biosolutions AB Medical SpecialtiesHealth Technology Magnetic Biosolutions AB develops medical instruments and software. The company specializes in the development of instruments, software, and protocols for sample preparation using magnetic bead technology. It was founded in 2000 and is headuqartered in Stockholm, Sweden. | Health Technology |
| Barracuda Invest AS | |
Cimon Medical AS
Cimon Medical AS Electronic Equipment/InstrumentsElectronic Technology Cimon Medical AS develops and manufactures applications for continuous monitoring blood flow. The company is based in Trondheim, Norway. The Norwegian company was founded in 2019 by Tormod Thomsen, Siri Ann Nyrnes. Tormod Thomsen has been the CEO since 2019. | Electronic Technology |
Defibrio AS
Defibrio AS Medical SpecialtiesHealth Technology Defibrio AS is a Norwegian company that focuses on saving lives by providing immediate access to automatic external defibrillators (AEDs). The company is based in Fana, Norway and was founded in 2020. The company's mission is to increase the survival rate of sudden cardiac arrest (SCA), which currently has a low survival rate of 10%%. SCA kills millions of people worldwide every year, with 70%% of deaths occurring in the home. Defibrio aims to reduce the chance of death by providing quick access to AEDs. The CEO is Arne Gjerde Bergby. | Health Technology |
- Stock Market
- Insiders
- Mårten Wigstøl
